Introduction: I think the authors could make a stronger argument for why widespread screening is needed. For example, in the Discussion section, it states: "HIV testing methods patients are continuing to present late…there are undiagnosed infections in all catchment areas…" I think some of the information that is presented in the Discussion presents more compelling reasons for why opt-out screening is important. Additionally, "new diagnoses are occurring in people who know their risk factor but are reluctant to disclose it…" and "people do not disclose their risk factors to their doctor…" Widespread screening would likely be beneficial in terms of helping to reduce stigma and this information (in the Discussion section) could be presented in the Introduction to present evidence for the benefits of opt-out testing.
Results: Was there any difference among persons who agreed to participate in the study from those persons who did not participate? Please briefly state if any information was collected on persons who did not participate in the study.
Results: "There were no reported issues from patients regarding the opt-out screening process". Was this asked in a formal questionnaire? Would this also count as a bias in that individuals who decided to take part in the study would be less likely to report any issues regarding the opt-out screening process as opposed to those individuals who did not take part in the study?
Discussion: The authors mention, "further studies are needed to determine the cost-effectiveness of opt-out testing in different studies…" Cost-effectiveness is an important issue when speaking to diagnosis (and it could be argued that widespread screening strategies are not cost-effective). Could the authors elaborate on this point further? Are there any additional drawbacks to opt-out testing?
Discussion: "so these data are also valuable in informing further screening practices". Could the study authors briefly elaborate on how the data presented informs screening practices? Specific Comments: Abstract: "Current screening is mainly risk-based and is suboptimal". Do the authors mean, "Globally, current screening is…"? Please add a word here to increase clarity. Abstract: "acceptability of this approach in our setting…" -Because the reader does not yet know the setting the authors are speaking to, this is a bit confusing as written. Please modify to increase clarity (e.g. could remove "of this approach in our setting"). Abstract: Is it possible to mention the city where the study took place? It gives readers an idea of whether it was a rural or urban based hospital.
Abstract: Was there an age minimum for persons who could consent to be the study? If yes, please mention here as part of the inclusion criteria.
Strengths and limitations: "high risk patients may have opted out of BBV panel testing." Although this could be possible, I am not sure why this would be an assumption? Is there any evidence that would indicate that this in the case in similar studies?
Introduction: "In Ireland, there has been a rise in newly reported HIV infections in recent years…" Could the authors please provide a brief followup statement as to why this would be the case? Is this a rise in new HIV infections? Or does the evidence indicate that this is due to an increase in people getting tested?
"It is estimated that many HCV infections in Ireland are undiagnosed." Please state a percentage here to give the reader an idea of how many persons are un-diagnosed. I think that this is also an ideal space to mention the main transmission routes for HCV in Ireland. This section on HCV infection is a bit limited (especially in comparison to the HBV section).
"No widespread screening programme is in place, so it is likely…" Could this also be said of HIV infections and HCV infections? I think that statements which apply to all three infectious diseases (HIV, HCV, and HBV) could be made in separate paragraph. In the last paragraph of the Introduction, please consider stating the aim or objective of this study.
"It was also the first to….in this population": To increase clarity, please consider stating the population group.
Methods: "with the main condition that patients should be allowed 20 minutes to decide on participation". Is it possible to explain this statement (briefly) in further detail? For example, patients should be allowed 20 minutes to decide on participation because…" Otherwise, please consider removing this statement.
"emergency department" (also used as 'ED' previously). Please modify to ED. "within a very busy service". Please consider adding some detail about how many people this hospital services (or what the authors mean by 'busy').
"Results were managed as per protocol". It might help to provide some information here as to what is meant by 'protocol'. Also, were all the samples analysed at the hospital?
Results: In the Results section, 'Hepatitis C' and 'HCV' are both used. Please modify as needed.
Discussion: "The AMU is a very busy department…" I think it would benefit the study if the authors provided some additional detail as to what is meant by 'busy' in this case. For example, how many patients does this service attend to?
Please consider rephrasing this sentence: "The large difference between uptake rates in the AMU and ED studies with comparison to those in the Primary Care setting may reflect…versus a large team of providers in an ED or AMU setting". Please more directly state how this relocation may have impacted the study.
"We did not collect any patient feedback." Given that the study authors did not collect any patient feedback, would it be possible to provide more detail as to what the authors mean when they state that the study was "feasible and acceptable to both patients and staff".
REVIEWER
Dr Caroline Rumble UK REVIEW RETURNED 11-Apr-2018
GENERAL COMMENTS
This is a study that attempts to assess the feasibility and acceptability of opt-out blood borne virus screening in an acute medicine unit in Ireland. I found the paper to be generally readable and clear but have a number of points / suggestions to make:
1) Authors to explain AMU-VS acronym 2) Including the demographics of all patients presenting to the AMU in the intervention time period and comparing these to those who were screened could be useful in understanding which patients were less likely to be screened (in the absence of other specific information explaining this).
3) Figure 2 represents the main results but is only briefly referred to in the text. Acknowledgement and explanation of the decline in testing rate during the middle and towards the end of the study period, as shown in this figure, is required. It would also be interesting to know if further strategies were employed after the dip in the middle of the study period to increase testing rates again.
4) The authors conclude that the opt out strategy is acceptable to both staff and patients however the stated limitations include that uptake may have been affected by healthcare worker reluctance and no patient / staff feedback was sought. Further, without a true denominator of eligible individuals and a break down of reasons for not being tested (e.g. testing not offered, bloods not taken, patient refusal to participate in the study, medical reason etc.) I feel the conclusion that testing is acceptable needs to be further qualified. Any further specific information on the reasons for the low uptake may assist the reader to understand whether testing was acceptable to staff and patients. Currently this paper presents feasibility more than acceptability. The limitations of this study are vital to understanding the screening uptake rate and therefore further explanation of these would be helpful. Thank you both very much for your very valuable comments. All comments relating to minor formatting issues have been addressed in the paper. In this letter I will refer to the bigger questions regarding format, structure and content of the article, in the order in which the comments were given.
As per Alison Marshall's comments we have restructured the introduction to speak about each infectious disease separately. We have also taken on board the suggestion of moving a number of points from the discussion to the introduction in order to strengthen our argument for widespread screening. Thank you very much for this very valuable input, we agree that the information flows better with these changes.
Regarding the results, due to the study design we were not able to ascertain if there were differences between those who parcipitated in the study and those who did not; we did not get ethical approval to collect information on those who opted out. This was discussed prior to the study and it was agreed that the goal should be to make study as easy as possible to facilitate in a busy unit, and that trying to collect information on or from those who did not participate (via questionnaire or otherwise) would make the study less easily encorporated into the work flow, and hence make it more difficult to assess feasibility. We have added a more specific explanation of this to the paper, including in limitations.
Regarding the discussion, we agree that cost-effectiveness is an important issue and hence have included a comment on this in the discussion.
Regarding the specific comments, we have reworded the abstract to include more detailed information as to the setting as suggested, and have clarified the age minimum for consent. We have also reworded the phrase "high risk patients may have opted out of BBV panel testing" as there is no evidence to suggest that those who opted out were of higher or lower risk, nor did we find any evidence in the literature that would support this. In the introduction we have stated more clearly the reasons for the recent rise in newly reported HIV infections in ireland, and we have added more detail to the HCV section, including the estimated rates of undiagnosed infection in Ireland. In methods we have explained in more detail why patients were given 20 minutes to decided; this was one of the stipulations from the ethical review board. In the results section we have clarified the protocol and included the information that the samples were analysed on-site. In the discussion we have included numbers of patients seen in the AMU to support our statement that it is a busy department. And finally and importantly, we have removed our comment that our study shows acceptability, as we did not ask for patient and staff feedback. Hence we have revised this to show feasibility only.
Dr Caroline Rumble made some similar comments on acceptability and on understanding why many patients opted out. Additionally, she commented on the acronym in the title, which we have now removed. We have strengthened the reference to figure 2 and explained the decline at the time of relocation of the AMU -including visual representation of this on the graph -and the tail off towards the end of the study, as well as commenting on strategies employed to try and counter this dip.
Thank you very much for the reference regarding HBV in low prevalence settings -we have included this in our section on HBV, and also updated other references as suggested. We have also made revisions to the graphs to include more detailed title, and addressed missing axis scales.
Regarding the editorial requests, we have revised the title of our study accordingly, including taking out the acronym. Similarly the abstract has been reformatted. We have commented more specifically on the sufficiency of verbal consent alone, as approved by the ethics committee. We have also included an upload of a completed STROBE checklist with the revised manuscript as requested.
VERSION 2 -REVIEW

REVIEWER
Alison Marshall
The Kirby Institute, University of New South Wales REVIEW RETURNED 04-Sep-2018
GENERAL COMMENTS
The authors are commended for making substantial changes to the manuscript. The Results section is appropriately concise, and the Discussion section provides some important comments about implementation about this type of research study into clinical care more generally. I have a few additional comments for their consideration that may be helpful.
General Comments:
The Introduction section is a bit lengthy. I think that some of the information could be presented in a Specific Comments: Abstract: I think the authors could state a slightly stronger rationale for the purposes of this study. For example, "…have greatly improved prognoses. However, to increase treatment uptake, improved efforts are critically needed to identify persons with these viruses. Current screening practices are mainly risk-based…" Abstract: Please consider adding a few words to: "Current screening is mainly risk-based…". For example, "Current screening practices are risk-based…" or "Current screening practices follow a risk-based model", etc.
Abstract: Please consider removing "in an area of presumed low prevalence of BBVs." This statement can be elaborated on in the Introduction (with references). It seems a bit out of place in the Abstract section.
Abstract: Please consider adding period of recruitment in the Abstract. Introduction: "Current doctors call for doctors to offer people HIV tests…" Please consider adding a reference here.
Introduction: "The CDC estimates that if everyone with HIV infection was diagnosed…" Please consider adding a reference here.
Introduction: "Late diagnosis of HIV leads to increased morbidity and mortality." Please consider adding a brief statement here with "increased morbidity and mortality due to…"
Entire document: Please refer the document for any acronyms that need to be spelled out the first time (e.g. HPSC). Similarly, Emergency Department is "ED" is capitalised (in Diagnosis and Screening section) and then not in the Methods section. Methods: "a very busy service". Please consider removing this term as this could be subjective (yes, the service provides 5,000 new consultations per year, but to an international audience from an international hospital based elsewhere, this might not be considered "busy"). Similarly, please consider removing the phrase, "The AMU is a very busy department" (from the Discussion section) as this is also a subjective statement.
Methods: "In a timely and prompt way…". Please consider quantifying this statement (e.g. 60 minutes?) or if this is not possible, please consider removing "in a timely and prompt way" as this could be viewed as subjective.
Methods: "Patient and Public Involvement". Is this section required? If not, please consider removing.
Methods: "the unexpected relocation of the AMU department". Please briefly describe the extent of the relocation (to a different section of the hospital?).
Discussion: Please consider changing IDU to PWID, as PWID is the more commonly accepted terminology. Discussion: Would it be possible for the authors to briefly comment on whether the results would be generalisable to other areas of Ireland? For example, when the authors state that the uptake was lower than that "in a study "conducted across for urban Primary Care sites.", it is not clear if these urban Primary Care sites were based in Ireland?
Discussion: Please add a title to the Table and any necessary footnotes. Discussion: "All patients attending for care in the AMU were included, however those over 65 years of age are not recommended for routine testing in current US guidelines." -Why is the article speaking to US guidelines in this context?
Discussion: "opt-out testing removed the stigma associated with BBV testing for both patient and the provider…" Please consider adding a reference here. Similarly, "the method of opt-out testing removes the stigma of BBV testing…" Please consider adding a reference here.
Discussion: "who were in fact at high-risk for BBV may have declined screening and therefore our study may have underestimated prevalence…" While it is possible that this is the case, it would be difficult to determine that persons, particularly with HBV, would decline to take part if they did not know the risk factors for HBV in the first place. Conclusion: "These data are valuable in order to inform further screening and prevention strategies for these infections in a low prevalence setting…". Please consider providing one sentence here to elaborate on how the data informs "further screening and prevention strategies". Similarly, the statement "also valuable in informing further screening practices". Please consider either removing this statement (as you could speak to the statement above) or elaborating on this statement. The authors are commended for making substantial changes to the manuscript. The Results section is appropriately concise, and the Discussion section provides some important comments about implementation about this type of research study into clinical care more generally. I have a few additional comments for their consideration that may be helpful.
The Introduction section is a bit lengthy. I think that some of the information could be presented in a Addressed in the text -incorporating into daily practise and ongoing education of healthcare practitioners about the lack of need for extensive pre-test counselling.
Specific Comments: Abstract: I think the authors could state a slightly stronger rationale for the purposes of this study. For example, "…have greatly improved prognoses. However, to increase treatment uptake, improved efforts are critically needed to identify persons with these viruses. Current screening practices are mainly risk-based…"
Changed as suggested Abstract: Please consider adding a few words to: "Current screening is mainly risk-based…". For example, "Current screening practices are risk-based…" or "Current screening practices follow a riskbased model", etc.
Changed as suggested Abstract: Please consider removing "in an area of presumed low prevalence of BBVs." This statement can be elaborated on in the Introduction (with references). It seems a bit out of place in the Abstract section.
Removed
Abstract: Please consider adding period of recruitment in the Abstract.
Limited by word-count so we have left this in the methods section Introduction: "Current doctors call for doctors to offer people HIV tests…" Please consider adding a reference here.
Addressed
This was referenced at end of paragraph but we have added the reference here too
Introduction: "Late diagnosis of HIV leads to increased morbidity and mortality." Please consider adding a brief statement here with "increased morbidity and mortality due to…" added Entire document: Please refer the document for any acronyms that need to be spelled out the first time (e.g. HPSC). Similarly, Emergency Department is "ED" is capitalised (in Diagnosis and Screening section) and then not in the Methods section. Methods: "a very busy service". Please consider removing this term as this could be subjective (yes, the service provides 5,000 new consultations per year, but to an international audience from an international hospital based elsewhere, this might not be considered "busy"). Similarly, please consider removing the phrase, "The AMU is a very busy department" (from the Discussion section) as this is also a subjective statement.
We have removed this statement as suggested.
Methods: "In a timely and prompt way…". Please consider quantifying this statement (e.g. 60 minutes?) or if this is not possible, please consider removing "in a timely and prompt way" as this could be viewed as subjective. Addressed -yes moved to a different part of the hospital Discussion: Please consider changing IDU to PWID, as PWID is the more commonly accepted terminology.
Changed accordingly Discussion: Would it be possible for the authors to briefly comment on whether the results would be generalisable to other areas of Ireland? For example, when the authors state that the uptake was lower than that "in a study "conducted across for urban Primary Care sites.", it is not clear if these urban Primary Care sites were based in Ireland?
Yes these were based in Ireland and we have clarified this in the manuscript Discussion: Please add a title to the Table and any necessary footnotes. Discussion: "All patients attending for care in the AMU were included, however those over 65 years of age are not recommended for routine testing in current US guidelines." -Why is the article speaking to US guidelines in this context?
These are the same guidelines referenced above from WHO so have changed the wording to clarify this Discussion: "opt-out testing removed the stigma associated with BBV testing for both patient and the provider…" Please consider adding a reference here. Similarly, "the method of opt-out testing removes the stigma of BBV testing…" Please consider adding a reference here.
Reference added
Discussion: "who were in fact at high-risk for BBV may have declined screening and therefore our study may have underestimated prevalence…" While it is possible that this is the case, it would be difficult to determine that persons, particularly with HBV, would decline to take part if they did not know the risk factors for HBV in the first place.
Have clarified that this is particularly in relation to HIV/ HCV, which are more stigmatised that HBV Conclusion: "These data are valuable in order to inform further screening and prevention strategies for these infections in a low prevalence setting…". Please consider providing one sentence here to elaborate on how the data informs "further screening and prevention strategies". Similarly, the statement "also valuable in informing further screening practices". Please consider either removing this statement (as you could speak to the statement above) or elaborating on this statement.
Addressed in the text
Conclusion: The authors conclude with a strong point about the need for cost-effective analyses.
Have any analyses been done in Ireland with regards to one-time screening for BBVs? If yes, please consider mentioning the cost-effectiveness piece in the Discussion section.
No there are no studies to date done in Ireland, have updated the text to clarify this, and re-iterated the previous reference to modelling studies on cost-effectiveness done elsewhere.
VERSION 3 -REVIEW
REVIEWER
Alison Marshall
The Kirby Institute, UNSW Sydney Centre for Social Research in Health, UNSW Sydney (coappointment) REVIEW RETURNED 17-Nov-2018
GENERAL COMMENTS
The study authors have provided sufficient edits to the manuscript. Namely, the aims are clearly stated, tables have been added to increase clarity, and the discussion section is thorough. I have provided some very minor follow-up comments below for your consideration.
Specific Comments: Abstract, Results, p.2: Please consider adding the standard deviation for the mean age (similar to the Results section).
Strengths and Limitations, p.3: "It shows that routine…" I think this sentence could be reduced to: "Routine opt-out screening for all viruses was feasible for patients and staff and could help to remove stigma associated with testing of these viruses."
Introduction, p.3: Please consider adding references after the sentence, "Infection with HIV…globally, including in Ireland…" and "screening has both personal and public health benefits."
Introduction, p.3: "and therefore are more likely to present late…" I understand what the authors are stating here, however, to increase clarity for the (non-clinical) audience, please consider adding a few words after "present late" (e.g. "present late with advanced disease"; "present late with advanced symptoms"; "present late to health services"…etc.).
Introduction, p.3: Because "it is estimated" is used in two back-toback sentences, please consider modifying to "approximately 90% of persons diagnosed with HIV infection in Ireland…" Introduction, p.4: "The START trial", please consider adding months/years, e.g. "The START trial (March-May 2016) showed clinical benefits for patients (n=?) who commenced treatment early in their disease course…" Introduction, p.4: Please move the present late definition "defined as CD4 count <350" to the previous sentence. For example, "However, with current testing methods, patients are continuing to present late (defined as CD4 count <350)."
Introduction, p.4: "providers often fail to find the time…" Given that this is a subjective statement, please consider modifying to "most providers do not make this assessment." Introduction, p.4: Please add a reference following the sentence, "HCV infection…preventing complications related to liver failure…". Please also provide a reference following the sentence, "suppression through treatment in infected individuals and through vaccination of close contacts."
Diagnosis and screening, p.5: "in certain circumstances…" Please consider adding a brief example, "in certain circumstances, e.g. blood donation (Table 1) ."
Methods, p.6: For the ethics approval, please spell out "GUH".
Methods, p.6: "time to read and assimilate the patient information…" The term assimilate in this case is awkward. Please consider changing to: "adequate time to read the patient information leaflet, which outlined the study details." (or something like this). Similarly, "each patient was given a patient information leaflet by the administration staff to review" or "to review and ask questions about the study."
Methods, p.6: It is not absolutely necessary, but it might be helpful to briefly state, "Patients did not receive reimbursement for their inclusion in the study."
Inclusion Criteria, p.6: Targets for the uptake of screening were set at 50%...80% from month onwards…" Please provide either a reference here or brief rationale for these set targets.
Discussion, p.7: "The overall diagnosed prevalence rate …was lower than previously reported." Please provide a reference here.
Discussion, p.7: "This prevalence of 0.5/1000 does not meet…in the British recommendations for…" Please provide a reference here.
Discussion, p.8: I am not sure that Table 2 is absolutely needed (could be listed as a Supplementary Table instead as it currently cuts into the Discussion section) but can also understand why the authors wanted to provide this information.
VERSION 3 -AUTHOR RESPONSE
Dear Dr Sucksmith and reviewer 1, Thank you for your response and for your recommendation of publication of our manuscript.
We have addressed the editorial requests regarding the STROBE checklist and attach the updated strobe checklist which references the comments on bias, study size and statistical methods in the manuscript.
We have also made all further changes and references suggested by the reviewer in order to make the manuscript read as clearly as possible -thank you very much for this input. We have opted to leave Table 2 in the main manuscript as we do feel it aids visualisation and comparison of results from different settings and we hope that this is acceptable to the reviewers and to the editorial team; if not we have no objection to moving it to the supplementary index.
VERSION 4 -REVIEW
REVIEWER
Alison Marshall
The Kirby Institute, UNSW Sydney REVIEW RETURNED 13-Feb-2019
GENERAL COMMENTS
General Comments: Please review the article for consistent use of acronyms. For example, "Acute Medical Unit" (p.3) is also used as "acute medical unit" (p.3) and "Acute Medical Assessment Unit" setting. Please also check with "HCV" and "hepatitis C" throughout (p. 9).
Because "areas of high endemicity" is mentioned (in relation to HBV) several times in the paper, it might be helpful to mention in the HBV section, some regions of the world where HBV prevalence is high.
Please also double-check referencing format (in the References section).
Specific Comments:
Title: Please clarify the study design. It is currently listed as, "Cross-sectional observational prospective study".
Introduction: "All three viral infections…lower rates of onwards transmission." Please add a reference here.
Introduction: "Furthermore these infections often occur in marginalised groups…" Please add a reference here.
Introduction: "Forty-five percent of those presenting with HIV in Ireland in 2015 presented late." Please add a reference here.
Introduction: "Of note, there have been an increase in sexually transmitted HCV infections in MSM from 4 in 2014 to 29 in 2016." Please consider adding an additional detail here. Where is this sample from? (location). Is this a hospital-based or regionally based survey?
Methods: Please briefly mention the statistical analysis that will be conducted in the study.
Methods: Please briefly more clearly state in the inclusion criteria that participants were consenting to have their blood tested for the BBV panel testing.
Results: "1936…assessed for medical care…" And then it states, "These 1941 samples…." Please clarify.
Results: One of the aims of this study was to assess the feasibility of an opt-out screening strategy. Please indicate how feasibility was measured in the Methods section.
Discussion: "This uptake rate…" Time is not used as a measurement in this case and thus, would not normally use the term "rate" in this case.
Discussion: "The percentage uptake of 40.4% is higher than previous studies in AMU settings…" Please briefly list the percentage of the previous studies here.
Discussion: "This uptake rate was calculated based on the assumption that all patients attending the AMU had blood drawn and therefore were eligible for the study. There may have been some patients who did not have bloods done…" Please clarity this statement. How often do the study authors anticipate that this would have been the case? Do the study authors have access to the number of blood tests that were conducted in total? If no, it might be worth listing this in the study limitations section.
Discussion: "This likely reflects that patients triaged to AMU are not fully representative of the local population…" Please consider adding a reference here.
Discussion: "2006 WHO Guidelines" -Are there more recent WHO guidelines that can be cited here?
Discussion: "Does not meet…British recommendations" -Would Ireland typically follow what is recommended for Britain?
Discussion: "This study helped to raise awareness about BBVs in the AMU". Because this was not directly measured in the study, the authors might want to modify to, "We believe that this study…"
VERSION 4 -AUTHOR RESPONSE
Dear Dr Sucksmith,
We would like to thank you and Dr Marshall for all of your comments and feedback to date; we believe that our manuscript is much better as a result. We believe we have now addressed Dr. Marshall's new comments on the most recent round of feedback. We have detailed point by point below the changes that have been made in response to these new suggestions, and hope that the editorial team are happy with the final manuscript.
Many thanks,
Niamh Allen
On behalf of the study team General Comments: Please review the article for consistent use of acronyms. For example, "Acute Medical Unit" (p.3) is also used as "acute medical unit" (p.3) and "Acute Medical Assessment Unit" setting. Please also check with "HCV" and "hepatitis C" throughout (p. 9).
We have reviewed all acronyms in the article and capitalised the use of "acute medical unit" in all instances. Acute medical assessment unit was not used on any occasion in the manuscript. We have uniformly used HCV for hepatitis C virus (with the exception of abstract where the full version is used on first mention, with the acronym in brackets), and with the exception of the mention of named guidelines (p4 -National Hepatitis C strategy) and references, where we have kept the paper name in its original format.
Because "areas of high endemicity" is mentioned (in reltion to HBV) several times in the paper, it might be helpful to mention in the HBV section, some regions of the world where HBV prevalence is high.
We have mentioned areas of high prevalence for HBV and added a reference here as suggested.
We have double-checked the referencing format in conjunction with the desired referencing format for the journal and added month last accessed for any URL references.
Specific Comments: Title: Please clarify the study design.
The title of the study on last submission was "cross -sectional observational prospective study; this was an error on our side and are grateful to Dr Marshall for pointing this out. It should read "Crosssectional observational study". It does not make sense to have a cross sectional prospective study and we believe this is what Dr Marshall meant.
Introduction: "All three viral infections…lower rates of onwards transmission." Please add a reference here. Introduction: "Furthermore these infections often occur in marginalised groups…" Please add a reference here. Introduction: "Forty-five percent of those presenting with HIV in Ireland in 2015 presented late." Please add a reference here.
We have added references to each of these statements as suggested.
We have elaborated that this is national data from the Health Protection Surveillance Centre (HPSC) ; this is a national body whose responsibility is the collation of national surveillance data on infections for all of Ireland (as referenced).
The data is primarily descriptive and analysis is as described in the methods.
We have added "at least 20 minutes later and with verbal consent" to further clarify this point.
There were 5 duplicate samples, and we have added a comment to this effect in the manuscript to clarify.
We have added a comment on the feasibility of the study, which was assessed by the BBV test uptake.
We have removed the word rate from this sentence and anywhere else in the paper.
We have added the percentages from the references studies, which had an uptake ranging from 6-22%.
Discussion: "This uptake was calculated based on the assumption that all patients attending the AMU had blood drawn and therefore were eligible for the study. There may have been some patients who did not have bloods done…" Please clarity this statement. How often do the study authors anticipate that this would have been the case? Do the study authors have access to the number of blood tests that were conducted in total? If no, it might be worth listing this in the study limitations section.
We feel that the number of patients not having bloods drawn would have been very small, and we have added to this to limitations as suggested. We do have access to the number of blood tests done in total, as already discussed in the manuscript, and used as our denominator. This number represents closely the number of attendees to the AMU, as very few patients would not have had bloods drawn.
The population of patients attending the AMU are a subset of those attending the emergency department. They are selected medical patients, excluding those coming to the emergency department with surgical presentations, injuries etc. As mentioned in the manuscript, they tend to be older and have more medical comorbidities. As such, by definition they are not a representative sample of the general population. We have amended this statement to "that patients triaged to the AMU may not be fully representative of the local population…" to avoid presumptions.
There are more recent guidelines however our intended point here was that the guidelines have recommended this from as early as 2006 ie. For over a decade, yet in many areas implementation is not up to speed. We have re-written this sentence to make it more clear why we are referencing older guidelines.
Yes, Ireland are very closely aligned to British Guidelines for many areas of infectious disease medicine, particularly when it comes to BBVs, for which there are no Irish guidelines.
We have changed this sentence as suggested.
